ANDA 75101, held by Watson Labs. Acyclovir.
As of Nov 13, 2026, ANDA 75101 (Acyclovir), held by Watson Labs, was first approved by FDA on Apr 15, 1998, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 15, 1998 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Acyclovir200MG ยท capsule;oral | Acyclovir | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed weekly; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
